Search

Your search keyword '"Shibata H"' showing total 48 results

Search Constraints

Start Over You searched for: Author "Shibata H" Remove constraint Author: "Shibata H" Topic hypertension Remove constraint Topic: hypertension
48 results on '"Shibata H"'

Search Results

1. 2023 update and perspectives.

2. Associations of Diabetic Retinopathy Severity With High Ambulatory Blood Pressure and Suppressed Serum Renin Levels.

3. Recent progress in the diagnosis and treatment of primary aldosteronism.

6. Pitfalls in the diagnosis and treatment of a hypertensive patient with unilateral primary aldosteronism and contralateral pheochromocytoma: a case report.

7. CASZ1: a promising factor modulating aldosterone biosynthesis and mineralocorticoid receptor activity.

8. Importance of dietary salt restriction for patients with primary aldosteronism during treatment with mineralocorticoid receptor antagonists: The potential importance of post-treatment plasma renin levels.

9. Mechanisms of mineralocorticoid receptor-associated hypertension in diabetes mellitus: the role of O-GlcNAc modification.

10. Update on Hypertension Research in 2021.

11. Optimal blood pressure target to prevent severe hypertension in pregnancy: A systematic review and meta-analysis.

12. Japan Endocrine Society clinical practice guideline for the diagnosis and management of primary aldosteronism 2021.

13. Effects of renal denervation on blood pressures in patients with hypertension: a systematic review and meta-analysis of randomized sham-controlled trials.

14. Statement of the Asian Hypertension Society Network: the Okinawa Declaration on the unity of hypertension societies in Asian countries and regions to overcome hypertension and hypertension-related diseases.

15. Annual reports on hypertension research 2020.

17. Association between MR-proADM concentration and treatment intensity of antihypertensive agents in chronic kidney disease patients with insufficient blood pressure control.

18. Efficacy and safety of esaxerenone (CS-3150), a newly available nonsteroidal mineralocorticoid receptor blocker, in hypertensive patients with primary aldosteronism.

20. Historical changes and between-facility differences in adrenal venous sampling for primary aldosteronism in Japan.

21. The Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH 2019).

22. Intestinal Mineralocorticoid Receptor Contributes to Epithelial Sodium Channel-Mediated Intestinal Sodium Absorption and Blood Pressure Regulation.

23. High Glucose Stimulates Mineralocorticoid Receptor Transcriptional Activity Through the Protein Kinase C β Signaling.

24. [Secondary hypertension].

25. [Diabetes mellitus related common medical disorders : recent progress in diagnosis and treatment. Topics: I. Pathophysiology, diagnosis and treatment: 3. Primary aldosteronism, resistant hypertension and diabetes mellitus].

26. Mineralocorticoid receptor-associated hypertension and its organ damage: clinical relevance for resistant hypertension.

27. Interaction of BMP10 with Tcap may modulate the course of hypertensive cardiac hypertrophy.

28. Antihypertensive effect of angiotensin I-converting enzyme inhibitory peptides from a sesame protein hydrolysate in spontaneously hypertensive rats.

29. Relation between blood pressure and rhinitis in a Japanese adolescent population.

30. Trends in pharmacologic management of hypertension in Japan one year after the publication of the JSH 2000 guidelines. First Japanese Society of Hypertension.

31. [Secondary hypertension].

32. Risk factors associated with persistent postoperative hypertension in Cushing's syndrome.

33. Determinants for the development of hypertension in adolescents. A 6-year follow-up.

34. [Screening of secondary hypertension].

35. [Epidemiology of secondary hypertension].

36. Plasma aldosterone concentrations are not related to the degree of angiotensin-converting enzyme inhibition in essential hypertensive patients.

37. Angiotensin II type 1 receptor messenger RNA levels in human blood cells of patients with primary and secondary hypertension: reference to renin profile.

38. [Inhibitory mechanism of experimental stress ulcer in spontaneously hypertensive rats (SHR) from the view point of mucosal blood flow].

39. Increased expression of vascular angiotensin II type 1A receptor gene in glucocorticoid-induced hypertension.

40. Case report: hypertension in Cushing's syndrome.

42. Ontogeny of calcium transport by intestinal Golgi in spontaneously hypertensive rats and genetically matched WKY rats.

43. Intestinal calcium transport in spontaneously hypertensive rats and their genetically matched Wistar-Kyoto rats. I. Endoplasmic reticulum.

44. Intestinal calcium transport in spontaneously hypertensive rats (SHR) and their genetically matched WKY rats.

47. Effects of hypertension and antihypertensive drugs on cardiovascular complications in the elderly.

48. Assessment of cardiopulmonary baroreflex function in hypertensive and normotensive subjects with or without hypertensive relatives.

Catalog

Books, media, physical & digital resources